Description: DMCI Holdings, Inc., through its subsidiaries, engages in general construction, coal and nickel mining, power generation, real estate development, water concessionaire, and manufacturing businesses in the Philippines and internationally. The company operates through seven business units: Construction and Others, Coal Mining, Nickel Mining, Real Estate, On-Grid Power, Off-Grid Power, and Water. It constructs various projects comprising high-rise, commercial, and residential buildings; institutional facilities; heavy civil works, roads, bridges, power plants, industrial plants, and water and sewer facilities, as well as chapels, hotels, irrigation dams, power transmission lines, and theaters. The company is also involved in the construction component businesses, such as the production and trading of concrete products; electrical and foundation works; and steel fabrication handling, and electrical and foundation works. In addition, it engages in the development of mid-income residential properties under the DMCI Homes brand; generation of power through coal-fired and satellite power plants; exploration, mining, development, and sale of coal resources on Semirara Island in Caluya, Antique; mining, extracting, and selling of nickel, chromite, and iron laterite from Berong, Long Point, Moorsom, and Ulugan mines in Palawan, as well as from Acoje mines in Zambales; manufacture, marketing, distribution, and trading of cement, wires, wire ropes, and cables; and provision of water distribution and sewer services for the western side of Metro Manila and parts of Cavite. The company was incorporated in 1995 and is based in Makati City, the Philippines. DMCI Holdings, Inc. is a subsidiary of Dacon Corporation.
Home Page: www.dechra.com
24 Cheshire Avenue
Northwich,
CW9 7UA
United Kingdom
Phone:
44 1606 814730
Officers
| Name | Title |
|---|---|
| Mr. Ian D. Page | CEO, MD & Exec. Director |
| Mr. Paul Nicholas Sandland MAAT, FCCA | CFO & Exec. Director |
| Dr. Anthony Gerard Griffin | MD of Dechra Veterinary Products for Europe & Exec. Director |
| Mr. Patrick Meeus | Group Scientific Officer |
| Ms. Katy Clough | Group HR Director |
| Mr. Mike Eldred | Pres of North America |
| Ms. Melanie Hall | Company Sec. |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 20.284 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.5635 |
| Price-to-Sales TTM: | 0.0443 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |